Methyl 1-(4-fluorophenyl)cyclopropanecarboxylate

Catalog No. :
ACZNSE498
CAS No. :
943111-83-9
Molecular Formula :
C11H11FO2
Molecular Weight :
194.21

IUPAC Name:methyl 1-(4-fluorophenyl)cyclopropane-1-carboxylate

Methyl 1-(4-fluorophenyl)cyclopropanecarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g98%$124.00Login to see priceIn stockIn stock
25g98%$601.00Login to see priceInquiryIn stock
100g98%$2023.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 1-(4-fluorophenyl)cyclopropanecarboxylate
IUPAC Namemethyl 1-(4-fluorophenyl)cyclopropane-1-carboxylate
MDL No.MFCD18434442
Molecular FormulaC11H11FO2
Molecular Weight194.21
SMILESO=C(C1(C2=CC=C(F)C=C2)CC1)OC
InChI KeyPYHCKEAPWABESH-UHFFFAOYSA-N
SynonymCyclopropanecarboxylic acid, 1-(4-fluorophenyl)-, Methyl ester;Methyl 1-(4-fluorophenyl)cyclopropanecarboxylate;Methyl 1-(4-fluorophenyl)cyclopropanecarboxylate - [M72434]
CAS No.943111-83-9
PubChem CID20110258

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZNSE498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6 In Stock
  4. Then
  5. ACZNSE498 route product structure diagram
    ACZNSE498943111-83-9 In Stock
Inquiry

2. ACZNSE498 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACXQWJ026 route compound structure diagram
    ACXQWJ026773100-29-1 In Stock
  4. Then
  5. ACZNSE498 route product structure diagram
    ACZNSE498943111-83-9 In Stock
Inquiry

Comments (0)